Frequency of Different Dermatoses Presented at OPD in Sir Syed Hospital Qayoomabad

May 2022 in “ Pakistan Journal of Medical and Health Sciences ”

Asia Hafeez, Shabnam Rani, Beenish Faisal, Priya Kumari Maheshwari, Abdul Haq Shaikh

acne scabies urticaria tinea corporis acne vulgaris melasma tinea cruris eczema

TLDR Young women were the most common patients at the dermatology clinic.

The retrospective study conducted at Sir Syed Hospital Qayoomabad analyzed one-year data from January to December 2018, involving 2,924 patients of both genders presenting with various dermatosis. The average age of the patients was 30.23 years, with females making up 66.4% (1,942) of the patients and males 33.6% (982). The most common dermatological diseases observed were Acne, Scabies, Urticaria, Tinea corporis, Acne vulgaris, Melasma, Tinea cruris, and Eczema, with their frequency varying according to seasonal changes. The study concluded that young females were the most frequent visitors to the dermatology OPD.

View this study on pjmhsonline.com →

Discuss this study in the Community →

Related Community Posts Join

6 / 582 results

community Fin completely cured my highly resistant hormonal acne 22m

in Finasteride/Dutasteride 7 upvotes 3 months ago

Finasteride effectively treated hormonal acne for multiple users, including the original poster. Topical treatments like Winlevi are effective but expensive and not always covered by insurance.

community biotin leads to acne and sebum on scalp ??

in Finasteride/Dutasteride 1 upvotes 7 months ago

User is experiencing increased sebum, dandruff, and acne after taking a supplement containing biotin, iron, zinc, and calcium pantothenate along with finasteride. They are questioning if biotin is the cause and whether they should stop taking it.

community Using WinLevi (Clascoterone) for Seborrheic Dermatitis and Acne

in Treatment 4 upvotes 10 months ago

Winlevi (clascoterone) is discussed as a treatment for hormonal acne and seborrheic dermatitis due to its ability to block DHT and regulate sebum production. The post suggests that Winlevi could offer a novel approach for managing seborrheic dermatitis.

community Cassiopea Announces FDA Submission of New Drug Application for Clascoterone Cream 1%, the First New Mechanism of Action for Acne in Nearly 40 Years

in Technology 28 upvotes 5 years ago

The conversation is about a new acne treatment cream called Clascoterone Cream 1%, which is the first new mechanism of action for acne in nearly 40 years. One person joked about hoping their face will be as clean as their bald head after using the cream.

community Kintor Pharma Announced Successful Dosing of the First Patient for Acne Vulgaris Phase II Clinical Trial of KX-826

in Research/Science 12 upvotes 2 years ago

Kintor Pharma successfully dosed the first patient in a Phase II trial for KX-826 for acne vulgaris. Users are more interested in results for male pattern baldness (MPB).

community Kintor Pharmaceutical Announces AR-PROTAC (GT20029) Approved for Acne and Androgenic Alopecia Clinical Trials in China

in Technology 14 upvotes 3 years ago

The conversation discusses the approval of Kintor Pharmaceutical's AR-PROTAC (GT20029) for clinical trials in China for acne and androgenic alopecia. One user expresses optimism about new treatments being developed and seeks clarification on how the new drug works, specifically if it temporarily degrades the AR protein to reduce DHT sensitivity in hair follicles.

Similar Research

5 / 1000+ results

research Skin Diseases in Pregnancy

34 citations, June 2014 in “The BMJ”

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.